el Daly E S
Department of Biology, Faculty of Education, Suez Canal University, Egypt.
J Pharm Belg. 1997 Jul-Aug;52(4):149-56.
Gentamicin, a nephrotoxic aminoglycoside antibiotic, was injected into adult male albino rats, alone or together with methimazole and fish oil. The effects on renal and liver functions and renal thiol status were studied. Gentamicin was administered as two i.p. injections (40 mg/kg body weight) for 3, 7 and 10 consecutive days. The animals were sacrificed 12 hours after the last injection. In gentamicin-treated rats, for 7 and 10 days, blood urea nitrogen (BUN) and serum creatinine concentrations and urinary N-acetyl-beta-D-glucosaminidase (NAG) activity were significantly increased compared with saline-treated controls. Administration of methimazole (20 mg/kg) and fish oil (5 ml/kg) together with gentamicin partially protected against the nephrotoxicity induced by gentamicin by returning the urea and creatinine concentrations and urinary NAG activity to normal levels, despite having higher kidney gentamicin concentrations, especially with methimazole. Rats given gentamicin alone for 3 days exhibited no elevation of BNU, serum creatinine and urinary NAG values. However, these rats exhibited an increase in nonprotein disulfide concentrations and a decrease in renal protein thiol and protein disulfide concentrations, as opposed to rats given gentamicin and methimazole and rats given gentamicin and fish oil. These results show that methimazole and fish oil were effective antagonists of gentamicin-induced nephrotoxicity. Methimazole did not inhibit gentamicin renal uptake but may protect against gentamicin-induced nephrotoxicity by acting as an antioxidant within the kidneys. On the other hand, fish oil may protect against gentamicin-induced nephrotoxicity by counteracting the biochemical alterations induced by the drug in the renal cortex. We conclude that methimazole and fish oil may be compounds for reducing gentamicin-toxic side effects, including nephrotoxicity, without compromising its antibiotic activity.
庆大霉素是一种具有肾毒性的氨基糖苷类抗生素,将其单独或与甲巯咪唑及鱼油一起注射到成年雄性白化大鼠体内。研究了其对肾功能、肝功能及肾脏巯基状态的影响。庆大霉素通过腹腔注射给药(40毫克/千克体重),连续注射3天、7天和10天。在最后一次注射后12小时处死动物。在接受庆大霉素治疗7天和10天的大鼠中,与生理盐水处理的对照组相比,血尿素氮(BUN)、血清肌酐浓度及尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)活性显著升高。甲巯咪唑(20毫克/千克)和鱼油(5毫升/千克)与庆大霉素一起给药,尽管肾脏中的庆大霉素浓度较高,尤其是与甲巯咪唑一起使用时,但通过使尿素和肌酐浓度及尿NAG活性恢复到正常水平,部分保护了大鼠免受庆大霉素诱导的肾毒性。单独给予庆大霉素3天的大鼠,其BNU、血清肌酐和尿NAG值未升高。然而,与给予庆大霉素和甲巯咪唑的大鼠以及给予庆大霉素和鱼油的大鼠相反,这些大鼠的非蛋白二硫键浓度增加,肾脏蛋白巯基和蛋白二硫键浓度降低。这些结果表明,甲巯咪唑和鱼油是庆大霉素诱导肾毒性的有效拮抗剂。甲巯咪唑不抑制庆大霉素在肾脏的摄取,但可能通过在肾脏内充当抗氧化剂来保护免受庆大霉素诱导的肾毒性。另一方面,鱼油可能通过抵消药物在肾皮质诱导的生化改变来保护免受庆大霉素诱导的肾毒性。我们得出结论,甲巯咪唑和鱼油可能是在不损害其抗生素活性的情况下减少庆大霉素毒性副作用(包括肾毒性)的化合物。